WTAP-mediated m6A modification of JUNB contributes to poor prognosis of HCC patients through the NLRP3-GSDMD pathwayOACSCDCSTPCD
WTAP-mediated m6A modification of JUNB contributes to poor prognosis of HCC patients through the NLRP3-GSDMD pathway
Zhijia Sun;Yingjie Wang;Jiangbo Li;Zheng Zhang;Pu Liu;Ruiguan Wang;Zhuo Song;Yuzhu Tang;Chenhui Wang;Liang Guo
Department of Radiation Oncology,Air Force Medical Center PLA,Air Force Medical University,Xi'an,Shaanxi 710032,ChinaDepartment of Radiation Oncology,Air Force Medical Center PLA,Air Force Medical University,Xi'an,Shaanxi 710032,ChinaBioinformatics Center,Academy of Military Medical Sciences,Beijing 100850,ChinaBioinformatics Center,Academy of Military Medical Sciences,Beijing 100850,ChinaBioinformatics Center,Academy of Military Medical Sciences,Beijing 100850,ChinaDepartment of Hepatobiliary Surgery,The Eight Medical Center,Chinese PLA General Hospital,Beijing 100091,ChinaDepartment of Radiation Oncology,Air Force Medical Center PLA,Air Force Medical University,Xi'an,Shaanxi 710032,ChinaDepartment of Radiation Oncology,Air Force Medical Center PLA,Air Force Medical University,Xi'an,Shaanxi 710032,ChinaBioinformatics Center,Academy of Military Medical Sciences,Beijing 100850,ChinaBioinformatics Center,Academy of Military Medical Sciences,Beijing 100850,China
《中华医学杂志（英文版）》 2025 (5)
622-624,3
This work was supported by grants from the Capital's Funds for Health Improvement and Research(No.2022-25121).
评论